Zedelmayer Christine reported option exercise involving 14,584 derivative units of Equillium, Inc. at $0.00 for $0 on Jun 5, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Sr. Vice President and COO
Sr. Vice President and COO
Filed Jun 5, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
14,584Employee Stock Option (right to buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
25,521Direct
Trade date
Jun 5, 2026Option exercise
Filed
Jun 5, 2026, 4:42 PM ET0-day reporting delay
Accession
0001797818-26-000011Code M · Transaction 99330
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 5, 2026Sell14,584$2.93−$42,736.95Trade 99329
Jun 5, 2026Option exercise14,584$0.79$11,448.44Trade 99328
3 transaction rows in this filing. Joint filers share the same rows.

EQ price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
EQ · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −26%1w ago −1.4%1d ago +7.8%
Returns since7d −4.4%30d −1%90d180d1y

Footnotes in full

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.91 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.